Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

FDA Reviewing Osteoporosis Drugs for Esophageal Cancer Risk
Bloomberg
Thursday, July 21, 2011 - 2:01pm
tags:
FDA, osteoporosis, esophageal cancer, Roche, Novartis, bisphosphonates, Merck, Boniva, Reclast, Fosamax
Teva Settles Litigation With Novartis Over Generic Lotrel
Bloomberg Businessweek
Thursday, July 21, 2011 - 12:47pm
tags:
Teva Pharmaceuticals, Novartis, generics, Lotrel, antihypertensives
Icon goes on hiring spree as analysts chide CROs on deal risks
Fierce Biotech
Thursday, July 21, 2011 - 12:45pm
tags:
CROs, ICON, Parexel
Doctors writing fewer prescriptions for Abbott cholesterol drug
Chicago Tribune, IL
Thursday, July 21, 2011 - 12:28pm
tags:
Abbott Laboratories, Niaspan, cholesterol
As HPV data stacks up, Merck touts Gardasil for boys
Fierce Pharma
Thursday, July 21, 2011 - 12:26pm
tags:
HPV, Gardasil, vaccines, Merck
Actelion Expects Tracleer Competition, Has Quarterly Loss
Bloomberg
Thursday, July 21, 2011 - 12:26pm
tags:
earnings, Tracleer, Actelion
10 Biotech Takeover/LBO Targets With Bullish Options Sentiment
Seeking Alpha
Thursday, July 21, 2011 - 12:21pm
tags:
M&A, Chelsea Therapeutics, Amgen, Human Genome Sciences, Acorda Therapeutics, Celgene, Dendreon, InterMune, Biomarin, Alnylam, Exelixis
Biogen, Bayer MS Drugs Aren’t Cost Effective, Study Says
Bloomberg
Thursday, July 21, 2011 - 12:19pm
tags:
MS, multiple sclerosis, Biogen Idec, Bayer, Avonex, Betaseron
Alexion climbs 9% on forecast
Marketwatch
Thursday, July 21, 2011 - 12:17pm
tags:
Alexion
Express Scripts Will Buy Medco For $29 Billion
Pharmalot
Thursday, July 21, 2011 - 12:16pm
tags:
Medco, Express Scripts, M&A, PBMs
AstraZeneca: Too Few Eggs, Too Small a Basket?
WSJ Online
Thursday, July 21, 2011 - 12:15pm
tags:
AstraZeneca, blood thinners, Brilinta
EMA Says Benefits From Pfizer’s Champix Outweigh Heart Risks
Bloomberg
Thursday, July 21, 2011 - 12:09pm
tags:
Pfizer, Champix, EMA, Europe, smoking cessation
Pfizer Won’t Break Up Animal Unit as Lilly Shows Interest in Some Products
Bloomberg
Thursday, July 21, 2011 - 12:08pm
tags:
Pfizer, Eli Lilly, M&A, animal health
As Dapagliflozin Receives Negative Vote, What's Next for Bristol Myers?
Seeking Alpha
Thursday, July 21, 2011 - 10:57am
tags:
Bristol-Myers Squibb, Dapagliflozin, Pfizer, Eli Lilly, AstraZeneca, JNJ, Yervoy
Eli Lilly second-quarter earnings fall 11%
Marketwatch
Thursday, July 21, 2011 - 10:55am
tags:
earnings, Eli Lilly
AstraZeneca Rises After FDA Approval of Brilinta Blood-Thinner
Bloomberg
Thursday, July 21, 2011 - 10:55am
tags:
blood thinners, Brilinta, FDA, AstraZeneca
Pfizer Facebook Page Is Hacked By Script Kiddies
Pharmalot
Wednesday, July 20, 2011 - 6:49pm
tags:
Pfizer, Facebook, social media, hacking
Optimer Launches Dificid
Yahoo/Zacks.com
Wednesday, July 20, 2011 - 6:48pm
tags:
Optimer, Dificid, Cubist Pharmaceuticals, Clostridium Difficile, antibiotics
Merck's Shares Look Undervalued
Seeking Alpha
Wednesday, July 20, 2011 - 6:46pm
tags:
Merck
AstraZeneca Wins U.S. Approval for Blood Thinner Brilinta to Rival Plavix
Bloomberg
Wednesday, July 20, 2011 - 6:46pm
tags:
Plavix, blood thinners, AstraZeneca, Sanofi, Bristol-Myers Squibb, Brilinta

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline
Defluorination is Happening Inside You Right Now
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.